CellASIC Corp. (acquired by Merck Group)

Brief Description

CellASIC¨ ONIX Microfluidic Platform delivers precise control for live cell analysis experiments by facilitating long-term perfusion cell culture. Cutting-edge microfluidics technology provides an improved cell culture microenvironment, exceptional quality for high magnification microscopy, and superior media switching capabilities.

CallASIC Corp. was acquired by Merck and merged with EMD Millipore Corp. for € 21.7 million in cash in 2012.

Inventor

Tech Category

  • Research Tools

JOIN OUR NEWSLETTER